| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-106 |
Sentence |
denotes |
Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. |
| T1 |
0-106 |
Sentence |
denotes |
Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. |
| T2 |
107-117 |
Sentence |
denotes |
OBJECTIVE: |
| T2 |
107-117 |
Sentence |
denotes |
OBJECTIVE: |
| T3 |
118-306 |
Sentence |
denotes |
To compare the effect of interleukin (IL)-17, IL-1beta and TNF-alpha on chemokine production by human chondrocytes and synovial fibroblasts isolated from patients with osteoarthritis (OA). |
| T3 |
118-306 |
Sentence |
denotes |
To compare the effect of interleukin (IL)-17, IL-1beta and TNF-alpha on chemokine production by human chondrocytes and synovial fibroblasts isolated from patients with osteoarthritis (OA). |
| T4 |
307-540 |
Sentence |
denotes |
The expression of IL-1beta mRNA by OA chondrocytes was also assessed, as well as the presence and expression of IL-17 receptor (IL-17R) in OA chondrocytes and synovial fibroblasts after stimulation with IL-17, IL-1beta and TNF-alpha. |
| T4 |
307-540 |
Sentence |
denotes |
The expression of IL-1beta mRNA by OA chondrocytes was also assessed, as well as the presence and expression of IL-17 receptor (IL-17R) in OA chondrocytes and synovial fibroblasts after stimulation with IL-17, IL-1beta and TNF-alpha. |
| T5 |
541-548 |
Sentence |
denotes |
DESIGN: |
| T5 |
541-548 |
Sentence |
denotes |
DESIGN: |
| T6 |
549-677 |
Sentence |
denotes |
Synovial fibroblasts and chondrocytes isolated from patients with OA were stimulated in vitro with IL-17, IL-1beta or TNF-alpha. |
| T6 |
549-677 |
Sentence |
denotes |
Synovial fibroblasts and chondrocytes isolated from patients with OA were stimulated in vitro with IL-17, IL-1beta or TNF-alpha. |
| T7 |
678-811 |
Sentence |
denotes |
Supernatants were collected and immunoassayed for the presence of IL-8, GRO-alpha (CXC chemokines) and MCP-1, RANTES (CC chemokines). |
| T7 |
678-811 |
Sentence |
denotes |
Supernatants were collected and immunoassayed for the presence of IL-8, GRO-alpha (CXC chemokines) and MCP-1, RANTES (CC chemokines). |
| T8 |
812-899 |
Sentence |
denotes |
The cells were used to detect the presence of IL-17R and the expression of IL-17R mRNA. |
| T8 |
812-899 |
Sentence |
denotes |
The cells were used to detect the presence of IL-17R and the expression of IL-17R mRNA. |
| T9 |
900-989 |
Sentence |
denotes |
Stimulated chondrocytes were also used to detect IL-1beta production and mRNA expression. |
| T9 |
900-989 |
Sentence |
denotes |
Stimulated chondrocytes were also used to detect IL-1beta production and mRNA expression. |
| T10 |
990-1144 |
Sentence |
denotes |
RESULTS: IL-17 upregulated the release of IL-8 and GRO-alpha both by synovial fibroblasts and chondrocytes, and the release of MCP-1 only by chondrocytes. |
| T10 |
990-1144 |
Sentence |
denotes |
RESULTS: IL-17 upregulated the release of IL-8 and GRO-alpha both by synovial fibroblasts and chondrocytes, and the release of MCP-1 only by chondrocytes. |
| T11 |
1145-1319 |
Sentence |
denotes |
IL-17 was a weaker stimulator than IL-1beta and TNF-alpha, except for GRO-alpha release which was maximally upregulated by IL-1beta, less by IL-17 and minimally by TNF-alpha. |
| T11 |
1145-1319 |
Sentence |
denotes |
IL-17 was a weaker stimulator than IL-1beta and TNF-alpha, except for GRO-alpha release which was maximally upregulated by IL-1beta, less by IL-17 and minimally by TNF-alpha. |
| T12 |
1320-1405 |
Sentence |
denotes |
When compared to IL-1beta, IL-17 was more active on chondrocytes than on fibroblasts. |
| T12 |
1320-1405 |
Sentence |
denotes |
When compared to IL-1beta, IL-17 was more active on chondrocytes than on fibroblasts. |
| T13 |
1406-1532 |
Sentence |
denotes |
In chondrocytes the expression of IL-1beta mRNA was enhanced by IL-17 and TNF-alpha, with a maximum level reached by IL-1beta. |
| T13 |
1406-1532 |
Sentence |
denotes |
In chondrocytes the expression of IL-1beta mRNA was enhanced by IL-17 and TNF-alpha, with a maximum level reached by IL-1beta. |
| T14 |
1533-1597 |
Sentence |
denotes |
IL-17 and TNF-alpha stimulated IL-1beta release in few subjects. |
| T14 |
1533-1597 |
Sentence |
denotes |
IL-17 and TNF-alpha stimulated IL-1beta release in few subjects. |
| T15 |
1598-1703 |
Sentence |
denotes |
Neither IL-17, IL-1beta nor TNF-alpha modulated the presence of IL-17R and the expression of IL-17R mRNA. |
| T15 |
1598-1703 |
Sentence |
denotes |
Neither IL-17, IL-1beta nor TNF-alpha modulated the presence of IL-17R and the expression of IL-17R mRNA. |
| T16 |
1704-1716 |
Sentence |
denotes |
CONCLUSIONS: |
| T16 |
1704-1716 |
Sentence |
denotes |
CONCLUSIONS: |
| T17 |
1717-1968 |
Sentence |
denotes |
These data suggest that IL-17 could contribute to cartilage breakdown and synovial infiltration in OA by inducing both the release of chemokines by chondrocytes and synovial fibroblasts and, in a less extent, the synthesis of IL-1beta by chondrocytes. |
| T17 |
1717-1968 |
Sentence |
denotes |
These data suggest that IL-17 could contribute to cartilage breakdown and synovial infiltration in OA by inducing both the release of chemokines by chondrocytes and synovial fibroblasts and, in a less extent, the synthesis of IL-1beta by chondrocytes. |